Title : Trastuzumab in combination with gemcitabine and vinorelbine as second-line therapy for HER-2/neu overexpressing metastatic breast cancer.

Pub. Date : 2006 Aug

PMID : 16820921






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The aim of this study was to evaluate the safety and efficacy of combined treatment with trastuzumab (T), gemcitabine (gem) and vinorelbine (vin) as second-line therapy for HER-2 overexpressing metastatic breast cancer, pretreated with anthracyclines and/or taxanes and/or trastuzumab. gemcitabine erb-b2 receptor tyrosine kinase 2 Homo sapiens